The potential role of miRNAs in the pathogenesis of salivary gland cancer–A Focus on signaling pathways interplay

AI Abulsoud, SS Elshaer, AA El-Husseiny… - … -Research and Practice, 2023 - Elsevier
Salivary gland cancer (SGC) is immensely heterogeneous, both in terms of its physical
manifestation and its aggressiveness. Developing a novel diagnostic and prognostic …

Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation

CQ Zhu, W Shih, CH Ling, MS Tsao - Journal of clinical pathology, 2006 - jcp.bmj.com
Characteristics of the tumour that affect and predict the survival outcome of patients with
cancer are prognostic markers for cancer. In non-small cell lung carcinoma (NSCLC), stage …

Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma

S Gout, E Brambilla, A Boudria, R Drissi, S Lantuejoul… - 2012 - journals.plos.org
Splicing abnormalities frequently occur in cancer. A key role as splice site choice regulator is
played by the members of the SR (Ser/Arg-rich) family of proteins. We recently demonstrated …

Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy

V Ritter, F Krautter, D Klein, V Jendrossek… - Cell death & …, 2021 - nature.com
Hypoxia, a characteristic of most human solid tumors, is a major obstacle to successful
radiotherapy. While moderate acute hypoxia increases cell survival, chronic cycling hypoxia …

Future options of molecular-targeted therapy in small cell lung cancer

AB Schulze, G Evers, A Kerkhoff, M Mohr… - Cancers, 2019 - mdpi.com
Lung cancer is the leading cause of cancer-related deaths worldwide. With a focus on
histology, there are two major subtypes: Non-small cell lung cancer (NSCLC)(the more …

Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples

S Grisaru‐Granovsky, Z Salah, M Maoz… - … journal of cancer, 2005 - Wiley Online Library
Protease activated receptors (PAR) form a family of G‐protein coupled receptors (GPCR)
encoding their own ligands and uniquely activated via proteolytic cleavage. Although …

[HTML][HTML] Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non–small-cell lung cancer

LH Schmidt, D Goerlich, T Spieker, C Rohde… - Journal of Thoracic …, 2014 - Elsevier
Introduction Apoptosis is a crucial pathway in tumor growth and metastatic development.
Apoptotic proteins regulate the underlying molecular cascades and are thought to modulate …

Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer

I Valles, MJ Pajares, V Segura, E Guruceaga… - 2012 - journals.plos.org
Lung cancer is a leading cause of cancer death worldwide. Several alterations in RNA
metabolism have been found in lung cancer cells; this suggests that RNA metabolism …

High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology

VK Anagnostou, FJ Lowery, V Zolota, V Tzelepi… - BMC cancer, 2010 - Springer
Background Bcl-2 promotes cell survival by inhibiting adapters needed for the activation and
cleavage of caspases thus blocking the proteolytic cascade that ultimately dismantles the …

Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma

SG Sanchez-Ceja, E Reyes-Maldonado… - Lung Cancer, 2006 - Elsevier
Experimental evidence suggests that in lung cancer, development, progression and an
increased proliferation rate can be linked to apoptosis-related factors. The objective of this …